Achmea Investment Management B.V. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Achmea Investment Management B.V. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2023$602
-14.6%
19,5850.0%0.01%
-35.0%
Q1 2023$705
-51.4%
19,585
-50.0%
0.02%
-59.2%
Q4 2022$1,450
-99.8%
39,170
+100.0%
0.05%
+75.0%
Q3 2022$787,000
+3647.6%
19,585
+3888.8%
0.03%
+2700.0%
Q2 2022$21,000
+23.5%
4910.0%0.00%0.0%
Q3 2021$17,000
-98.6%
491
-98.2%
0.00%
-97.6%
Q1 2021$1,173,00026,8910.04%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders